首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1521392

全球植入式心律管理设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Implantable Cardiac Rhythm Management Devices Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 124 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球植入式心律管理设备市场需求预计将从 2023 年的 150.7 亿美元增至 2032 年的近 278.5 亿美元，2024-2032 年研究期间复合年增长率为 7.06%。

植入式心律管理 (CRM) 装置包括一系列旨在监测和管理心律不整（例如心律不整和心搏过缓）的医疗设备。这些设备透过手术植入体内，其功能是调节心臟的电活动，确保适当的心率和节律。植入式心律管理设备包括透过提供电脉衝刺激心臟来治疗心搏过缓的起搏器，以及监测心律并根据需要提供电击或起搏以防止心臟骤停的植入式心律转復除颤器( ICD)。

市场动态

全球人口老化，加上心血管疾病的日益流行，患者数量显着扩大，需要植入式心律管理设备。这种人口结构的变化凸显了对能够有效监测和调节心律的植入式设备的日益增长的需求，从而降低与心律不整相关的死亡率。技术和设备功能的进步正在推动市场扩张。设备小型化、更长的电池寿命、增强的诊断功能以及与远端监控系统的兼容性等创新提高了设备功效和患者治疗效果。这些技术进步提高了设备性能，有助于提高患者的便利性和治疗依从性。此外，预防性医疗措施和主动慢性病管理的日益采用正在推动植入式心律管理设备的成长。医疗保健提供者和患者对心律不整的早期诊断和介入的好处的认识不断提高，推动了植入式 CRM 设备的更高利用率。然而，与设备植入和维护相关的高成本以及植入设备的初始费用阻碍了植入式心律管理设备市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球植入式心律管理设备市场的各个细分市场进行了包容性评估。植入式心律管理设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

植入式心律管理设备市场报告的这一部分提供了有关国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按产品分类

心律调节器（传统心律调节器、无引线心律调节器）
ICD（单腔 ICD、双腔 ICD）
CRT（CRT-除颤器、CRT-心律调节器）

按最终用途

医院
专科心臟中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲植入式心律管理设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。植入式心律管理设备市场的主要参与者包括美敦力、雅培、波士顿科学公司、皇家飞利浦公司、佐尔医疗公司、百多力、史赛克、席勒公司、日本光电公司、微创科学公司。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：植入式心律管理设备公司的竞争格局

植入式心律管理设备市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Medtronic

公司简介
公司收入
产品
最近的发展

Abbott

公司简介
公司收入
产品
最近的发展

Boston Scientific Corporation

公司简介
公司收入
产品
最近的发展

Koninklijke Philips NV

公司简介
公司收入
产品
最近的发展

Zoll Medical Corporation

公司简介
公司收入
产品
最近的发展

Biotronik

公司简介
公司收入
产品
最近的发展

Stryker

公司简介
公司收入
产品
最近的发展

Schiller AG

公司简介
公司收入
产品
最近的发展

Nihon Kohden Corporation

公司简介
公司收入
产品
最近的发展

Microport Scientific Corporation

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112115231

The global demand for Implantable Cardiac Rhythm Management Devices Market is presumed to reach the market size of nearly USD 27.85 Billion by 2032 from USD 15.07 Billion in 2023 with a CAGR of 7.06% under the study period 2024-2032.

Implantable cardiac rhythm management (CRM) devices encompass a range of medical devices designed to monitor and manage heart rhythm disorders, such as arrhythmias & bradycardia. These devices are surgically implanted within the body and function to regulate the heart's electrical activity, ensuring appropriate heart rate and rhythm. Implantable cardiac rhythm management devices include pacemakers for treating bradycardia by delivering electrical impulses to stimulate the heart and implantable cardioverter-defibrillators (ICDs) that monitor heart rhythms and deliver shocks or pacing as needed to prevent sudden cardiac arrest.

MARKET DYNAMICS

An aging population globally, coupled with the increasing prevalence of cardiovascular diseases, is significantly expanding the patient pool, requiring implantable cardiac rhythm management devices. This demographic shift highlights the growing need for implantable devices that can effectively monitor and regulate heart rhythms, thereby reducing mortality rates associated with cardiac arrhythmias. Advancements in technology and device capabilities are driving market expansion. Innovations such as miniaturization of devices, longer battery life, enhanced diagnostic features, and compatibility with remote monitoring systems improve device efficacy and patient outcomes. These technological advancements enhance device performance and contribute to patient convenience and compliance with therapy. Moreover, the rising adoption of preventive healthcare measures and proactive chronic disease management are fuelling the growth of implantable cardiac rhythm management devices. Rising awareness among healthcare providers & patients about the benefits of early diagnosis and intervention for cardiac rhythm disorders drives higher utilization of implantable CRM devices. However, the high costs associated with device implantation and maintenance and the initial expense of implantable devices, pose hinder the implantable cardiac rhythm management devices market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Implantable Cardiac Rhythm Management Devices. The growth and trends of Implantable Cardiac Rhythm Management Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Implantable Cardiac Rhythm Management Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Pacemaker (Conventional Pacemakers, Leadless Pacemaker)
ICDs (Single Chamber ICDs, Dual Chamber ICDs)
CRT (CRT-Defibrillator, CRT-Pacemaker)

By End-Use

Hospitals
Specialty Cardiac Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Implantable Cardiac Rhythm Management Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Implantable Cardiac Rhythm Management Devices market include Medtronic, Abbott, Boston Scientific Corporation, Koninklijke Philips N.V., Zoll Medical Corporation, Biotronik, Stryker, Schiller AG, Nihon Kohden Corporation, Microport Scientific Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By End-Use
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data Analysis By Product
5.3. Pacemaker (Conventional Pacemakers, Leadless Pacemaker) Historic and Forecast Sales By Regions
5.4. ICDs (Single Chamber ICDs, Dual Chamber ICDs) Historic and Forecast Sales By Regions
5.5. CRT (CRT-Defibrillator, CRT-Pacemaker) Historic and Forecast Sales By Regions

6. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY END-USE

6.1. Overview By End-Use
6.2. Historical and Forecast Data Analysis By End-Use
6.3. Hospitals Historic and Forecast Sales By Regions
6.4. Specialty Cardiac Centers Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES COMPANIES

8.1. Implantable Cardiac Rhythm Management Devices Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF IMPLANTABLE CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Medtronic
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Abbott
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Boston Scientific Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Koninklijke Philips N.V.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Zoll Medical Corporation
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Biotronik
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Stryker
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Schiller AG
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Nihon Kohden Corporation
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Microport Scientific Corporation
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Product (USD MN)
Pacemaker (Conventional Pacemakers, Leadless Pacemaker) Market Sales By Geography (USD MN)
ICDs (Single Chamber ICDs, Dual Chamber ICDs) Market Sales By Geography (USD MN)
CRT (CRT-Defibrillator, CRT-Pacemaker) Market Sales By Geography (USD MN)
Analysis By End-Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Specialty Cardiac Centers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Implantable Cardiac Rhythm Management Devices Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Implantable Cardiac Rhythm Management Devices Report
Market Research Process
Market Research Methodology
Global Implantable Cardiac Rhythm Management Devices Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By End-Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Product (USD MN)
Pacemaker (Conventional Pacemakers, Leadless Pacemaker) Market Sales By Geography (USD MN)
ICDs (Single Chamber ICDs, Dual Chamber ICDs) Market Sales By Geography (USD MN)
CRT (CRT-Defibrillator, CRT-Pacemaker) Market Sales By Geography (USD MN)
Global Market Analysis By End-Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Specialty Cardiac Centers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis